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Plasma cholecystokinin levels and gallbladder 
volumes after proctocolectomy with ileal 
pouch-anal anastomosis
Jan M. J. I. Salemans, MD, Paul W. L. Thimister, MD, Wim P. M. Hopman, PhD,
Han C. Kuijpers, PhD, Gerd Rosenbusch, PhD, Fokko M. Nagengast, PhD, and
Jan B. M. J. Jansen, PhD, Nijmegen3 The Netherlands
Background . The colon and rectum contain regulatory peptides in mucosal endocrine cells, which 
suggests a hormonal role, In  animal studies colectomy leads to increased plasma levels of 
cholecystokinin, Little  is known about the effects of proctocolectomy with ileal pouch-anal 
anastomosis on the release of cholecystokinin in human beings. Therefore we studied the effects o f 
this procedure on fasting, postprandial, and bombesin-stimulated plasma cholecystokinin levels and  
gallbladder volumes,
M ethods, Ten patients who had undergone proto colectomy with ileal pouch-anal anastomosis and  
12 healthy volunteers participated in the study. Fasting and postprandial plasma cholecystokinin 
levels and gallbladder volumes were studied for 3 hours at 15-minute intervals, In  a second 
experiment plasma cholecystokinin levels were measured before and during intravenous 
administration of bombesin in six patients with ileal pouch and five healthy volunteers.
Results. Fasting plasma cholecystokinin levels were higher (p < 0.05) in patients with ileal 
pouch-anal anastomosis (2.6 ±  0.3 p m o l/L )  compared with controls (1.7  ±  0.2 p m o l /L ) . 
Integrated postprandial plasma cholecystokinin levels were also distinctly higher (p < 0 .01) in 
patients (978 ± 126 p m o l/L  • 180 m in) than in controls (588 ±  60 p m o l/L  • 180 m in ). M ean  
fasting gallbladder volume was significantly (p < 0 ,01) decreased in patients with ileal 
pouch-anal anastomosis (18 ± 2 ml) compared with controls (28 ±  2 m l). Postprandial 
gallbladder em ptying as measured by percentage change was similar in both groups. After infusion 
of bombesin, integrated plasma cholecystokinin responses were higher (p <  0.05) in patients 
(161 ±  20 p m o l/L  • 20 m in) than in controls (90 ± 12 p m o l/L  ■ 20 m in ).
Conclusions. Fasting3 postprandial} and bombe sin-stimulated plasma cholecystokinin levels are 
elevated in patients with ileal pouch-anal anastomosis compared with controls> Fasting gallbladder 
volume is decreased after ileal pouch-anal anastomosis. These findings suggest that the colon
contains a factor that inhibits the release o f cholecystokinin, (SURGERY 1995;117:705-11.)
From the Departments of Gastroenterology and Hepatology, Surgery9 and Radiology,
University Hospital St. Radboud\ Nijmegen 3 The Netherlands
P r o c t o c o l e c t o m y  w i t h  ileal pouch-anal anastomo­
sis (IPAA) is an attractive and widely accepted alterna­
tive to permanent ileostomy in patients operated on for 
severe ulcerative colitis or familial polyposis coli, be­
cause the normal route of defecation is preserved.1,2 
Long-term functional results are generally gratifying 
because defecation frequency and degree of incontinence 
are acceptable in most patients.3”7 
The colon and rectum contain regulatory peptides in
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mucosal endocrine cells, which suggests a hormonal 
role.8 Harper et al.9 ,10 demonstrated that extracts from 
colonic and ileal mucosa of cats and pigs markedly 
inhibited both pancreatic protein secretion and gall­
bladder contraction. Intraluminal perfusion of the 
colon with nutrients induces endocrine effects* 6 Per­
fusion of the colon with oleic acid inhibits the release of 
cholecystokinin and pancreatic enzyme secretion in 
dogs.15 Moreover, it has been shown that subtotal 
colectomy results in an increased postprandial chole­
cystokinin release in rats and dogs.17,18 These findings 
suggest that the colon contains a factor that suppresses 
the release of cholecystokinin. Little is known, however, 
about the effects of proctocolectomy on gastrointestinal 
physiology and circulating gut hormone responses in 
human beings.
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The aim of this study was to examine the effect of 
proctocolectomy with IPAA on the release of cholecys- 
tokinin and gallbladder motility in human beings. 
Therefore we have studied fasting and postprandial 
plasma cholecystokinin levels and gallbladder volumes 
(GBVs) in these patients. The results were compared 
with those obtained in healthy volunteers. To study the 
release of cholecystokinin independently of a meal, we 
further have studied cholecystokinin secretion during 
intravenous administration of bombesin, a neuropeptide 
that potently stimulates the release of cholecystoki-
* 19-21mn.
METHODS
Subjects. Twelve healthy subjects (seven male and 
five female) and 10 patients who had undergone proc­
tocolectomy with IPAA (three male and seven female; 
three cases of familial polyposis coli and seven cases of 
ulcerative colitis) were studied. In all patients a J  pouch 
had been constructed 6 months to 7 years (median, 4 
years) before this study was performed. The diverting 
loop ileostomy had been closed in all. None of the pa­
tients with IPAA had experienced pouchitis. M ean age, 
weight, length, and body mass index (BMI) were sim­
ilar in both groups (Table). None of the healthy subjects 
had a history of previous abdominal operation or gas­
trointestinal disease, and none of the patients with IPAA 
had undergone cholecystectomy. Fasting plasma chole­
cystokinin levels were determined in an additional five 
patients with IPAA and three healthy volunteers (both 
groups, total 15 subjects). To assess whether postpran­
dial plasma cholecystokinin levels change with time of 
follow-up, the correlation between the integrated post­
prandial plasma cholecystokinin levels and the length of 
time after operation was calculated. Informed consent 
was obtained from each subject, and the protocol was 
approved by the Ethics Committee of the Nijmegen 
University Hospital.
Experimental protocol* All subjects reported at 8:30 
AM at the gastrointestinal research laboratory after an 
overnight fast. The subjects ingested a standardized 
breakfast (at t = 0 minutes) composed of one slice of 
bread, 5 gm butter, 20 gm cheese, one boiled egg, 150 
ml yogurt, and one cup of tea with 5 gm sugar (21 gm 
protein, 2 1 .5 gm fat, 34 gm carbohydrate). Venous blood 
samples for analysis of plasma cholecystokinin levels 
were drawn before (at t = [ < ] 0m;—5 and 0 minutes) 
and at 15-minute intervals from 0 to 120  minutes and 
at 30-minute intervals from 120 to 180 minutes after the 
meal through an indwelling catheter placed in an ante- 
cubital vein. Blood was collected into glass tubes 
containing ethylenediamine tetraacetic acid. After cen­
trifugation the separated plasma was frozen at —20° C 
until analysis. GBVs were measured at the same time 
points.
In a second experiment the response of plasma chole­
cystokinin to intravenous administration of bombesin (5 
ng/kg/m in) was measured in six patients with IPAA 
(two male and four female; mean age, 34 years; range, 
23 to 41 years) and five healthy volunteers (three male 
and two female; mean age, 47 years; range, 43 to 53 
years) after an overnight fast, Three of the six patients 
with IPAA had also participated in the first experiment. 
None of the patients with IPAA had experienced epi­
sodes with pouchitis. None of the healthy volunteers in 
the bombesin experiment had participated in the first 
experiment. Bombesin was administered through an 
indwelling catheter in an antecubital vein. Blood sam­
ples for determination of plasma cholecystokinin levels 
were drawn from a catheter in an antecubital vein in the 
opposite arm before and at 5-minute intervals for 20 
minutes during bombesin infusion.
G allb ladder emptying. GBV was measured by 
means of real-time ultrasonography with the sum of 
cylinders method by using a computerized method.22 In 
this method the longitudinal scan of the gallbladder is 
divided into a series of cylinders of equal height, with 
diameters perpendicular to the longitudinal axis of the 
gallbladder image. The uncorrected volume is the sum 
of volumes of these separate cylinders. To correct for the 
displacement of the longitudinal image of the gallblad­
der from the central axis, a correction factor is calculated 
from the longitudinal and transverse scans of the gall­
bladder. GBV is calculated by multiplication of the un­
corrected volume with the square of the correction fac­
tor. Two longitudinal and two transverse images of the 
gallbladder were obtained at each time point. The mean 
of two measurements was used for further analysis. The 
variation of GBV measurements by using this method 
ranges from 6.2% to 10.0%. Gallbladder emptying and 
percentage gallbladder emptying were calculated by 
using the following formulas:
Maximum gallbladder emptying = G B Vo — G B V min 
Percentage gallbladder emptying -  1 0 0% • (GBVo —
G B V min) /G B V 0
where GBVo is mean fasting GBV (average of GBV at 
t = ~5 and 0 minutes) and GBVm¡n is smallest post­
prandial GBV.
Plasm a cholecystokinin levels. Cholecystokinin was 
measured in plasma by a sensitive and specific radioim­
munoassay.231 24 The antibody used (T204) was raised 
in rabbit after the fourth immunization with albumin- 
coupled crude porcine cholecystokinin and used in a fi­
nal dilution of 1:80,000. The antibody binds to all car- 
boxy-terminal cholecystokinin peptides containing the 
sulfated tyrosyl region. The antibody shows less than 2% 
cross-reactivity with sulfated gastrins and does not bind 
to unsulfated forms of gastrin or structurally unrelated 
peptides, like insulin, secretin, pancreatic polypeptide,
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bombesin, and neurotensin. Synthetic human cholecys- 
tokinin33 coupled to 125I-hydroxyphenylpropionic acid 
succinimide ester (Bolton-Hunter reagent) was used as 
label and as standard preparation. The detection limit 
of this assay is 0.5 pmol/L. The intraassay variation 
ranges from 4.6% to 11.5% and the interassay variation 
from 11.3% to 26.1 7ö.
Statistical analysis. Results were expressed as 
mean ± SEM. Fasting plasma cholecystokinin levels 
and fasting GBVs were calculated as the mean of two 
basal measurements (—5 and 0 minutes). Integrated 
plasma cholecystokinin secretion in response to the meal 
or to bombesin infusion was determined by calculating 
the area under the plasma concentration versus time 
curve by using the trapezoidal rule. Statistical analysis 
was performed with Student’s t test for unpaired results 
or the rank sum test when appropriate. A two-tailed p  
value of less than 0.05 was considered statistically sig­
nificant. The correlation between integrated postpran­
dial plasma cholecystokinin levels and length of postop­
erative time of follow-up was calculated with the Pear­
son correlation coefficient.
RESULTS
Fasting and postprandial plasma cholecystokinin 
levels. Fasting plasma cholecystokinin levels were sig­
nificantly higher (fi < 0.05) in patients with IPAA 
(2.6 ±  0.3 pmol/L) compared with the healthy controls 
(1.7 ± 0.2 pmol/L). Postprandial plasma cholecysto­
kinin levels increased rapidly and significantly in both 
groups. In healthy volunteers the mean peak plasma 
cholecystokinin level was 4.2 ± 0 .5  pmol/L and in pa­
tients with IPAA 7.8 ± 1.1 pmol/L (p = 0.003). The 
mean time to peak plasma cholecystokinin levels was 
similar in both groups* 58 ± 12 minutes in healthy 
controls and 50 ±  11 minutes in patients with IPAA. 
Plasma cholecystokinin concentration versus time curves 
are shown in Fig. 1 . Integrated postprandial plasma 
cholecystokinin levels were significantly higher 
(p <  0.01) in the patients with IPAA (797 ± 77 pmol/ 
L • 180 min) compared with the healthy controls 
(516 ± 57 pmol/L • 180 min). Individual integrated 
postprandial plasma cholecystokinin levels are shown in 
Fig. 2 . The Pearson correlation coefficient between in­
tegrated postprandial plasma cholecystokinin levels and 
time of postoperative follow-up was —0.63 (p = 0.052).
Fasting GBVs and postprandial gallbladder emp­
tying. Fasting GBVs were significantly smaller 
(p <  0.01) in patients with IPAA (18 ± 2 ml) when 
compared with healthy controls (27 ± 2 ml). Individual 
fasting GBVs are shown in Fig. 3. Mean fasting and 
postprandial GBVs are depicted in Fig. 4. Maximum 
gallbladder emptying was 23 ± 2 ml in controls and 
15 ±  3 ml in patients with IPAA (p <0.01). The 
smallest GBVs were reached at 95 ± 13 minutes in pa-
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Fig. 1. Fasting and postprandial plasma cholecystokinin 
(CCK) levels versus time curves (mean ±  SEM) in controls 
(open markers) and patients with IPAA (closed markers) .
tients with IPAA (3 ±  1 ml) and at 81 ± 7  minutes (not 
significant) in controls (5 ± 1 ml, not significant). The 
percentage gallbladder emptying was similar in both 
groups (controls, 82% ± 3% ; patients with IPAA,
81% ±  4%, not significant). No correlation was ob-
i
served between fasting GBV and time of postoperative 
follow-up.
Plasma cholecystokinin responses to bombesin- 
infusion. Basal plasma cholecystokinin levels were 
similar in both groups (controls, 1.8 ±  0.3 pmol/L; 
patients with IPAA, 1.8 ± 0.4 pmol/L). During infu­
sion of bombesin the integrated plasma cholecystokinin 
response was significantly higher (p < 0.05) in patients 
with IPAA (161 ± 20 pmol/L • 20 min) compared 
with controls (90 ± 12 pmol/L • 20 min). Fig. 5 shows 
the mean plasma cholecystokinin time curves in five 
healthy controls and six patients with IPAA before and 
during infusion of bombesin.
DISCUSSION
In the present study we have demonstrated that post­
prandial and bombesin-stimulated plasma cholecysto­
kinin levels are increased after proctocolectomy with 
IPAA. To our knowledge this is the first time that the 
effect of proctocolectomy on plasma cholecystokinin 
levels and GBVs has been studied in human beings.
708 Salemans et al. Surgery
June 1995
Fig. 2. Individual integrated postprandial plasma cholecys­
tokinin (CCK) levels in healthy controls (open markers) and 
patients with IPAA (closed markers) . Integrated postprandial 
cholecystokinin levels were significantly higher in patients 
with IPAA (p <  0.01), Error bars indicate standard deviation.
Table. Gender, mean age, weight, height, and BMI 
of patients with IPAA and healthy volunteers 
(controls)
Controls
Patients  
with IP A A p  Value
Gender 1 M, 5 F 7 M } 3 F 0.67
Age (yr, range) 36.3 (22-61) 35.7 (22-49) 0.70
Weight (kg) 77 ±  3 77 ±  3 0.99
Height (m) 1.77 ±  0.03 1.75 ±  0.03 0.78
BMI (kg/m2) 24.9 ±  0.9 25.2 ±  0.9 0.80
No significant differences in these parameters between controls and patients 
with IPAA were observed,
Probably as a result of fasting hypercholecystokinemia, 
fasting GBVs are decreased in patients with IPAA. 
Basal plasma cholecystokinin levels were slightly but 
significantly elevated after proctocolectomy compared 
with the healthy controls in our meal study. However, 
in the bombesin study plasma cholecystokinin levels 
were similar in both groups. This apparent discrepancy 
is likely to be due to the small number of subjects in the
bombesin experiment compared with the meal study.
i
Therefore the power to detect a true difference in basal
60
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0
Fig. 3. Individual fasting GBVs in healthy controls (open 
markers) and patients with IPAA (closed markers). Error 
bars indicate standard deviation. Mean fasting GBV in 
healthy controls (28 ±  2  ml) was significantly higher com­
pared with patients with IPAA (18 ±  2 ml, p  <  0.01).
plasma cholecystokinin levels may have been too low in 
the bombesin experiment (type II error).
Previously it has been shown that subtotal colectomy 
results in an increased postprandial plasma cholecysto­
kinin release in rats and dogs*17*18 Pancreatic weight, 
digestive enzyme concentration, and secretion capacity 
increase after large bowel resection in rats .25 These ef­
fects are supposed to be induced by elevated plasma 
cholecystokinin levels.
Several mechanisms may account for the increased 
cholecystokinin levels after proctocolectomy. First, a 
negative feedback mechanism on the release of chole­
cystokinin exerted by an unknown inhibiting colonic 
factor may be eliminated after proctocolectomy. This 
hypothesis is supported by the finding that perfusion of 
the colon with oleic acid has been shown to inhibit pan­
creatic protein secretion in dogs,12 cats,13 and human 
beings.14,15 Inoue et al.16 have demonstrated that this 
inhibition of pancreatic exocrine protein secretion in 
dogs is due, at least in part, to suppression of cholecys­
tokinin release. Under normal conditions, however, nu­
trients like oleic acid do not enter the colon in concen­
trations used in these perfusion experiments. Therefore 
it is unclear whether these nutrients play a functional
Fasting gallbladder volume (mL)
Controls PAA
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Fig. 4. Mean (±SEM) fasting and postprandial GBVs in 
healthy controls (open markers) and patients with IPAA 
(closed markers) . Postprandial gallbladder emptying as mea­
sured by percentage change was similar in both groups,
role in a feedback control of proximal cholecystokinin 
release in healthy human beings.
Lluis et al.26 have shown that a substance released 
from the colon inhibits pancreatic secretion by inhibit­
ing cholecystokinin release in dogs. This substance, 
peptide YY (PYY), has been found primarily in mucosal 
endocrine cells in the ileum, colon, and rectum of sev­
eral species27"29 including human beings,30 Therefore 
proctocolectomy may lead to lower circulating PYY 
levels and hence to elevated plasma cholecystokinin lev­
els in human beings. Indeed, fasting PYY levels have 
been found to be decreased in patients who had under­
gone total colectomy31 or colonic resection with ileosto­
my.32 This topic, however, remains controversial be­
cause Armstrong et al.33 have found increased fasting 
and postprandial plasma PYY levels and increased tis­
sue levels of PYY 1 year after proctocolectomy with 
IPAA in dogs. It was suggested that an increased syn­
thesis and release of PYY are an adaptive process that 
may contribute to functional improvement by slowing 
small intestine transit. This suggestion is supported by 
studies of Pietroletti et al.,34 who found elevated fasting 
and postprandial PYY levels after proctocolectomy with 
IPAA in human beings. Although not of enough statis­
tical power (p = 0.052), we found a trend toward
14
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Fig. 5. Plasma cholecystokinin (CCK) response (mean ± 
SEM) to infusion of bombesin in five healthy controls (open 
markers) and six patients with IPAA (closed markers). In­
tegrated cholecystokinin response to bombesin infusion was 
significantly higher in patients with IPAA {p < 0.05).
declining cholecystokinin levels with time after opera­
tion, probably as a result of adaptation. It could be 
speculated that during follow-up after proctocolectomy 
PYY synthesis in the terminal ileum and circulating 
PYY levels gradually increase as a result of adaptation. 
Assuming a suppressive effect of PYY on the release of 
cholecystokinin, plasma cholecystokinin levels may ini­
tially increase after proctocolectomy and gradually de­
cline during follow-up.
Previous studies have shown that ileal perfusion of fat 
emulsions markedly inhibits gastric emptying, small 
bowel transit, and jejunal motor activity.35“37 This “ ileal 
brake55 correlates well to increased plasma levels of 
PYY,37 Intravenous infusion of PYY at physiologic lev­
els slows the mouth to cecum intestinal transit and the 
rate of gastric emptying.38,39 These data suggest that the 
ileal brake may be mediated in part by PYY, Small in­
testine transit is also slowed in patients with IPAA .40 It 
could be speculated that elevated PYY levels mediate 
this inhibition of small intestine transit. Removal of the 
colon does not eliminate the ileal brake because it has 
been shown that oleic acid infusion into the ileal pouch 
slows gastric emptying and small intestine transit and
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increases plasma levels of PYY.41,42 However, it is un­
clear to  what extent stool frequency is influenced by the 
ileal brake mechanism after proctocolectomy with IPAA. 
As a result of inflammation of the ileal mucosa, the pro­
duction of PYY might be decreased in patients with 
pouchitis. This might contribute to rapid small intestine 
transit and increased stool frequency in these patients.
F u rth e r studies are needed to evaluate the role of PYY 
in the adaptive response during follow-up after procto­
colectomy with IPAA and the relationship between 
plasm a levels of PYY and cholecystokinin, in patients 
both with and without pouchitis. Withdrawal of un­
known colonic factors with a possible inhibitory effect 
on th e  release of cholecystokinin may also induce 
hypercholecystokinemia after proctocolectomy.
Previously we have reported that postprandial conju­
gated serum bile acid levels are decreased in patients 
with IPAA compared with healthy subjects with an in­
tact colon .43 An increased fecal excretion of bile acids has 
been observed in patients with a Kock continent ileosto- 
my44“46 anc[ |n patients with IPAA 47>48 Probably bile
acids are reabsorbed less effectively by the ileal pouch 
mucosa in comparison with the mucosa of the normal 
term inal ileum. The bile acid pool and the bile acid 
output into the duodenum decrease if fecal losses are 
substantial. Because the release of cholecystokinin is in­
hibited by bile acids in the duodenal lumen,49’ 50 elevated 
plasm a cholecystokinin concentrations after procto­
colectomy may also be due to a decreased load of bile 
acids in the proximal part of the small intestine.
In  conclusion, basal, postprandial, and bombesin- 
stimulated plasma cholecystokinin levels are elevated 
after proctocolectomy with ileal pouch-anal anastomo­
sis in  human beings. Probably as a result, fasting GBVs 
are decreased after proctocolectomy. The mechanisms 
responsible for hypercholecystokinemia in patients with 
IP A A  are still incompletely understood and need further 
investigation.
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